Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Cancer gene mutation and gene amplification detection

A gene and cancer technology, applied in the field of detection of genes with high incidence of cancer mutations, can solve problems such as improper primer concentration ratio, large sample consumption, and low cost

Active Publication Date: 2015-05-20
北京圣谷智汇医学检验所有限公司
View PDF4 Cites 30 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The fluorescent PCR method has the characteristics of high sensitivity, and the technology is mature and widely used. However, each pair of primers can only detect one mutation, and each mutation requires a separate PCR reaction system, resulting in a large amount of samples and cannot be detected at the same time. A large number of samples or sites; the first-generation Sanger sequencing method can detect multiple mutations with a single pair of primers, and has the characteristics of low cost, but only one pair of primers can be used for each amplification, which cannot detect multiple genes or multiple samples at the same time, and Large sample volume required and unsatisfactory detection of infrequent mutations
[0013] The traditional classic method for detecting gene amplification is FISH (fluorescence in situ hybridization), which has good sensitivity, and its biggest advantage is that it can visually observe the gene amplification at the nucleus level, and can be detected by the brightness of fluorescence. The strength of the gene is used to estimate the number of gene copies, but this method is costly and has high requirements for the operation of technicians, and its result judgment is easily affected by many factors, such as polyploid cells, etc.
[0014] Multiplex PCR technology is currently widely used in the amplification of multiple genes and multiple sites. Compared with ordinary PCR, it also has the advantages of high efficiency, quantitative or qualitative templates, etc., but its system construction needs to integrate the homology of the target sequence. Factors such as sex and length, primer kinetics, optimization of PCR reaction conditions, etc. For example, the length range of the target sequence is too large, which may lead to uneven amplification efficiency, improper primer concentration ratio, or the formation of dimers between primers can affect The overall amplification efficiency or amplification uniformity is generally less than five to six pairs of primers in the same system on the market or in experiments at the same time, which shows that it is quite difficult and demanding in terms of technical realization

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cancer gene mutation and gene amplification detection
  • Cancer gene mutation and gene amplification detection
  • Cancer gene mutation and gene amplification detection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0116] Example 1: Genomic DNA is amplified using the detection primer pair of SEQ ID NO:1-30 and the balanced primer pair of SEQ ID NO:31-230

[0117] The samples used were 136 cases of lung cancer samples. The genomic DNA was subjected to multiplex PCR amplification using the detection primer pair of SEQ ID NO: 1-30 and the balanced primer pair of SEQ ID NO: 31-230, and then sequenced using the ion PGM sequencer. The specific implementation method is as follows:

[0118] a) Genomic DNA extraction

[0119] According to the standard FFEP (formalin-fixed, paraffin-embedded) tumor tissue genomic DNA extraction method, using the E.Z.N.A. FFEP DNA kit (Omega Bio-Tek), according to the manufacturer's instructions, the genome was extracted from the FFEP-treated tissue DNA. The extracted DNA was subjected to gel electrophoresis and OD value measurement for quality control and quantification with a Qubit 2.0 fluorometer (Life Technologies). The DNA concentration is required to be gr...

Embodiment 2

[0154] Example 2: DNA mutation detection and Sanger verification of various tumor samples using multiplex PCR+high-throughput sequencing technology

[0155] 1. Multiplex PCR + high-throughput sequencing to detect base mutations

[0156] Six paraffin samples were taken from 2 cases of lung cancer, 1 case of colorectal cancer, 1 case of esophageal cancer, 1 case of gastric cancer, and 1 case of ovarian cancer. For sequencing, the specific steps of multiplex PCR and high-throughput sequencing are the same as in Example 1.

[0157] The sequencing results were compared with the reference sequence to obtain the mutation detection results, as shown in Table 9.

[0158] Table 96 multiplex PCR+high-throughput sequencing base mutation detection results of samples

[0159]

[0160] 2. Sanger verification of the test results

[0161] Primers were designed for the detected sites of each of the above samples, and PCR amplification was performed respectively. The PCR products were gel-...

Embodiment 3

[0174] Example 3: Application of multiplex PCR + high-throughput sequencing technology to detect HER2 amplification mutations in tumor samples and FISH verification

[0175] 1. Multiplex PCR + high-throughput sequencing to detect HER2 amplification mutations

[0176] When the HER2 gene of the sample is amplified, the amplified copy number of the target product will increase accordingly. By calculating the ratio of the copy number of the target sequence of the HER2 gene in the sample after normalization to the corresponding copy number in the control sample, the HER2 gene in the sample can be determined. Whether there is amplification phenomenon.

[0177] Take 7 cases of esophageal cancer and 21 cases of breast cancer paraffin samples, apply detection primers to SEQ ID NO:1-30 and balance primers to SEQ ID NO:31-230 for multiplex PCR amplification, use Ion PGM sequencer for sequencing, and detect HER2 gene amplification mutation, wherein the specific steps of multiplex PCR and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a primer set for simultaneously detecting mutation of a plurality of regions of two or more exons of one or more cancer drive genes in a sample on the basis of multiplex PCR (polymerase chain reaction) and high-flux sequencing techniques, a kit comprising the primer set, and a method for amplifying the cancer drive gene or detecting the cancer drive gene by using the primer set and / or kit. The mutation detection result can be used for instructing cancer clinic medication, auxiliary diagnosis or prognosis judgment on certain cancers.

Description

field of invention [0001] The invention relates to the detection of genes with high incidence of cancer mutations. The invention provides a primer set, a kit and a detection method for multigene and multisite mutation detection of cancer samples based on multiplex PCR and high-throughput sequencing technology. The provided test results can be used, for example, to assist diagnosis or guide clinical medication regimens. Background technique [0002] Cancer is one of the most important non-communicable diseases in the world, and it is also the chronic disease with the highest fatality rate. In my country, the number of deaths due to cancer is as high as 2.7 million every year, among which lung cancer, gastric cancer, colorectal cancer and other digestive tract tumors are the most serious. Gynecological tumors, led by breast cancer, are also the leading cause of cancer death in women. According to statistics, the incidence rate of lung cancer in my country is 53.57 / 100,000, an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68C12N15/11
CPCC12Q1/6886C12Q2600/106C12Q2600/118C12Q2600/156
Inventor 唐川宁刘志源楼峰陈思毅
Owner 北京圣谷智汇医学检验所有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products